Autologous TILs Expansion
Tumor Infiltrate Lymphocytes (TILs) are the key cells in Cancer Immunotherapy. The rapid expansion of autologous TILs provides enough number and quality of cells for customized in vitro experiments.
Solid Tumor
Tils Io

TILs

Rapidtilsexpansion
Rapidtilsexpansion
Plateb
  • Full Cell Profiling
  • Original Infiltration Rate Description
  • Original TILs Activation Status
  • IL2 / IL15 / IL21
  • Optional Step
  • Patient-matched Effector-Target Cells

Solid Tumor Sample

FCM Profiling

Rapid TILs Expansion

TILs Activation Step

Cells Retrieval
& FCM Readout

Rapid TILs Expansion Protocol:
Scalation nº for experimentation

  • Patient-Matched Effector:Target Cells
  • Effector:Target controled ratios
  • Killing potency upon Immune Therapy Regimen
  • Suitable for different tumor types
  • Frozen TILs Repository
Solid Tumor Sample
Solid Tumor
FCM Profiling
  • Full Cell Profiling
  • Original Infiltration Rate Description
  • Original TILs Activation Status
Tils Io

TILs

Rapid TILs Expansion
  • IL2 / IL15 / IL21
Rapidtilsexpansion
TILs Activation Step
  • Optional Step
Rapidtilsexpansion
Cells Retrieval
& FCM Readout
  • BsAbs TILs activation
Plateb
Rapid TILs Expansion Protocol:
Scalation nº for experimentation
  • Patient-Matched Effector:Target Cells
  • Effector:Target controled ratios
  • Killing potency upon Immune Therapy Regimen
  • Suitable for different tumor types
  • Frozen TILs Repository